Doctor profile · Federal record
Dr. Gayatri Nimmagadda, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Glen Burnie, MD
- NPI 1770550998
- Accepts Medicare
- MIPS 75.5 / 100 · 2023
- 41 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
305 Hospital Dr
Glen Burnie, MD 210615805
(410) 761-9896
fax (410) 761-2250
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- March 19, 2026
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D0039041
- Medicaid
- MD #210121100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770550998. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
346,332
Distinct HCPCS
10
Medicare allowed
$2,366,301
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 210,120 | 173 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 34,200 | 39 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 24,960 | 132 | $23 | |
J0185 |
Injection, aprepitant, 1 mg | 13,260 | 29 | $2 | |
J9267 |
Injection, paclitaxel, 1 mg | 12,322 | 13 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 11,630 | 15 | $54 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 10,400 | 76 | $20 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 7,400 | 23 | $6 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 4,086 | 58 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 2,296 | 24 | $0 |
In context: peer comparison
Among 2 peers in Glen Burnie Hematology & Oncology Physician, average services per provider: 4,783. This provider delivers 72× the peer median.Open Payments
Industry payments received
All-time total
$987
Transactions
31
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 6 | $161.20 | |
| Abbvie INC. | 3 | $97.66 | |
| AstraZeneca Pharmaceuticals Lp | 3 | $77.26 | |
| BeiGene USA, INC. | 2 | $63.25 | |
| Novartis Pharmaceuticals Corporation | 2 | $61.06 | |
| Sobi, INC | 2 | $59.38 | |
| Blueprint Medicines Corporation | 2 | $57.93 | |
| Lilly USA, LLC | 2 | $53.28 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $45.63 | |
| Pfizer INC. | 2 | $40.74 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $34.44 | |
| GlaxoSmithKline, LLC. | 1 | $34.24 | |
| Daiichi Sankyo INC. | 1 | $28.63 | |
| Rigel Pharmaceuticals, INC. | 1 | $27.91 | |
| Incyte Corporation | 1 | $27.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
691
Patients
213
Total drug cost
$2,169,380
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 109 | 42 | $4,313 |
| Gabapentin | Generic | 57 | 28 | $1,756 |
| Ondansetron Hcl | Generic | 56 | 28 | $788 |
| Hydroxyurea | Generic | 54 | 16 | $2,212 |
| Xarelto (Rivaroxaban) | Brand | 52 | 21 | $80,629 |
| Tamoxifen Citrate | Generic | 51 | 17 | $2,251 |
| Oxycodone Hcl | Generic | 49 | 18 | $861 |
| Letrozole | Generic | 45 | 13 | $2,414 |
| Ibrance (Palbociclib) | Brand | 35 | 0 | $577,019 |
| Revlimid (Lenalidomide) | Brand | 35 | 0 | $613,962 |
Frequently asked questions
What is Dr. Gayatri Nimmagadda's medical specialty?
Dr. Gayatri Nimmagadda practices Hematology & Oncology Physician in Glen Burnie, MD.
Where does Dr. Gayatri Nimmagadda practice?
Dr. Gayatri Nimmagadda practices at 305 Hospital Dr, Glen Burnie, MD 210615805. Office phone: 4107619896.
What is Dr. Gayatri Nimmagadda's NPI?
Dr. Gayatri Nimmagadda's National Provider Identifier (NPI) is 1770550998, issued by NPPES.
Does Dr. Gayatri Nimmagadda accept Medicare assignment?
Yes. Dr. Gayatri Nimmagadda accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gayatri Nimmagadda commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.